Showing results (61-70 of 1,827) with videos related to

Sort By:
Pageof 183
ESMO Open|August 9, 2021
Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literatureR Heregger, F Huemer, G Hutarew, et al.
ESMO Open|August 9, 2021
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 studyE Van Cutsem, A Valderrama, Y-J Bang, et al.
ESMO Open|August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world studyM Nannini, A Rizzo, M C Nigro, et al.
ESMO Open|August 13, 2021
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive reviewI Solares, D Viñal, M Morales-Conejo, et al.
ESMO Open|December 1, 2016
Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE studyC M Lund, D Nielsen, C Dehlendorff, et al.
ESMO Open|December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answersN I Cherny, R Sullivan, U Dafni, et al.
ESMO Open|December 10, 2016
Molecular pathology of cancer: how to communicate with diseasePeter Birner, Gerald Prager, Berthold Streubel
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
ESMO Open|November 16, 2016
Inter-institutional heterogeneity in outcomes of chemotherapy for metastatic gastric cancer: correlative study in the JCOG9912 phase III trialY Kurokawa, N Boku, T Yamaguchi, et al.
Pageof 183